EUVIMEDEUVIMED entdecken
Crossref

Isoniazid preventive therapy among HIV infected patients on antiretroviral therapy diagnosed with latent tuberculosis: A retrospective assessment of the outcome in Tanzania

Karol J Marwa, Rachel Maingu

Indian Journal of Tuberculosis · 2025

DOI: 10.1016/j.ijtb.2023.07.005 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Indian Journal of Tuberculosis, 2025. Verfasst von Karol J Marwa und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, Catholic University of Health and Allied Sciences, Mwanza, Tanzania. Electronic address: carol_maro@yahoo.com. Hauptthemen laut MEDLINE: Isoniazid, Antitubercular Agents, HIV Infections, Latent Tuberculosis. Die Arbeit nennt 36 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: People infected with HIV are at a higher risk up to 20-folds of developing active TB than those not infected with HIV. Isoniazid Preventive Therapy (IPT) is employed in HIV eligible individuals to prevent progression of active tuberculosis (TB) disease. However, there is limited data on the efficacy of IPT in clinical settings in Tanzania and other parts of the world. This study was carried to assess the real-time IPT effectiveness in preventing TB incidences among HIV infected individuals on antiretroviral therapy. METHODS: A retrospective cohort study was carried employing secondary data of 1000 HIV infected individuals receiving anti-retroviral therapy. TB incidence and associated factors were determined after a four years follow-up. RESULTS: A total of 1000 people were enrolled in the study. The mean age was 44.87 years. The incidence rate was 7.37/1000 person-years (PY) [95% confidence interval (CI) 3.96-13.71]. One percent (1%) of patients developed active tuberculosis within four years of follow up after receiving isoniazid tablets as part of IPT. CONCLUSION: IPT has a high efficacy in preventing active TB development among HIV infected individuals on ART in clinical settings thus warranting the scale up of IPT services in the country.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

IsoniazidAntitubercular AgentsHIV InfectionsLatent TuberculosisHumansTanzaniaRetrospective StudiesAdultMaleFemaleMiddle AgedIncidenceTreatment Outcome

Stichwörter der Autor:innen

Isoniazid preventive therapyTanzaniaTuberculosis

Substanzen

IsoniazidAntitubercular Agents

Autor:innen und Institutionen

  • Department of Pharmacology, Catholic University of Health and Allied Sciences, Mwanza, Tanzania. Electronic address: carol_maro@yahoo.com.
  • Moshi Municipal Council, Kilimanjaro Region, Tanzania.

Zitieren

APA

J Marwa, K., & Maingu, R. (2025). Isoniazid preventive therapy among HIV infected patients on antiretroviral therapy diagnosed with latent tuberculosis: A retrospective assessment of the outcome in Tanzania. Indian Journal of Tuberculosis. https://doi.org/10.1016/j.ijtb.2023.07.005

Vancouver

J Marwa K, Maingu R. Isoniazid preventive therapy among HIV infected patients on antiretroviral therapy diagnosed with latent tuberculosis: A retrospective assessment of the outcome in Tanzania. Indian Journal of Tuberculosis. 2025. doi:10.1016/j.ijtb.2023.07.005

BibTeX
@article{JMarwa2025,
  author = {J Marwa, Karol and Maingu, Rachel},
  title = {Isoniazid preventive therapy among HIV infected patients on antiretroviral therapy diagnosed with latent tuberculosis: A retrospective assessment of the outcome in Tanzania},
  journal = {Indian Journal of Tuberculosis},
  year = {2025},
  doi = {10.1016/j.ijtb.2023.07.005}
}
Kostenlos starten →